Literature DB >> 26305215

Correction: Characterization of the Newly Isolated Lytic Bacteriophages KTN6 and KT28 and Their Efficacy against Pseudomonas aeruginosa Biofilm.

Katarzyna Danis-Wlodarczyk, Tomasz Olszak, Michal Arabski, Slawomir Wasik, Grazyna Majkowska-Skrobek, Daria Augustyniak, Grzegorz Gula, Yves Briers, Ho Bin Jang, Dieter Vandenheuvel, Katarzyna Anna Duda, Rob Lavigne, Zuzanna Drulis-Kawa.   

Abstract

Entities:  

Year:  2015        PMID： 26305215      PMCID： PMC4549064          DOI： 10.1371/journal.pone.0137015

Source DB:  PubMed          Journal:  PLoS One        ISSN： 1932-6203            Impact factor:   3.240


× No keyword cloud information.
  1 in total

1.  Characterization of the Newly Isolated Lytic Bacteriophages KTN6 and KT28 and Their Efficacy against Pseudomonas aeruginosa Biofilm.

Authors:  Katarzyna Danis-Wlodarczyk; Tomasz Olszak; Michal Arabski; Slawomir Wasik; Grazyna Majkowska-Skrobek; Daria Augustyniak; Grzegorz Gula; Yves Briers; Ho Bin Jang; Dieter Vandenheuvel; Katarzyna Anna Duda; Rob Lavigne; Zuzanna Drulis-Kawa
Journal:  PLoS One       Date:  2015-05-21       Impact factor: 3.240
  1 in total
  3 in total

1.  Efficacy of three lytic bacteriophages for eradicating biofilms of multidrug-resistant Proteus mirabilis.

Authors:  Ahmed Esmael; Sabah A Abo-Elmaaty; Esraa M Khafaga; Soheir Abdelrahman; Mervat G Hassan
Journal:  Arch Virol       Date:  2021-09-24       Impact factor: 2.574

2.  Characterization of the first double-stranded RNA bacteriophage infecting Pseudomonas aeruginosa.

Authors:  Yuhui Yang; Shuguang Lu; Wei Shen; Xia Zhao; Mengyu Shen; Yinling Tan; Gang Li; Ming Li; Jing Wang; Fuquan Hu; Shuai Le
Journal:  Sci Rep       Date:  2016-12-09       Impact factor: 4.379

Review 3.  Challenges and Promises for Planning Future Clinical Research Into Bacteriophage Therapy Against Pseudomonas aeruginosa in Cystic Fibrosis. An Argumentative Review.

Authors:  Martina Rossitto; Ersilia V Fiscarelli; Paola Rosati
Journal:  Front Microbiol       Date:  2018-05-04       Impact factor: 5.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.